Clinical trial
Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm
NCT00454714 · Udo Sechtem, Other · Withdrawn
Key facts
| NCT number | NCT00454714 |
|---|---|
| Title | Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm |
| Official title | Application of Sildenafil in Patients With Documented Coronary Vasospasm to Explore the Pathophysiology of Coronary Vasospasm and the Therapeutic Effect of Sildenafil in Patients Suffering From Coronary Vasospasm |
| Lead sponsor | Udo Sechtem, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Vasospasm |
| Intervention type | Drug |
| Interventions | single dose Sildenafil, Single dose placebo |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 31, 2009 |
| Completion | Dec 31, 2009 |
| First posted | Apr 2, 2007 |
| Last update posted | Apr 12, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: